CF
BIIB icon

Copperwynd Financial’s Biogen BIIB Stock Holding History

Copperwynd Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,250
Closed -$1.78M – 131
2023
Q2 		$1.78M Buy
+6,250
New +$1.86M 0.83% 26
2023
Q1 		– Sell
-6,389
Closed -$1.77M – 137
2022
Q4 		$1.77M Buy
+6,389
New +$1.8M 0.99% 23
2018
Q3 		– Sell
-1,185
Closed -$344K – 95
2018
Q2 		$344K Buy
1,185
+34
+3% +$9.56K 0.24% 68
2018
Q1 		$315K Buy
1,151
+134
+13% +$41.6K 0.22% 72
2017
Q4 		$324K Buy
+1,017
New +$326K 0.24% 71

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Copperwynd Financial's BIIB Position: Q3 2023 in Review

Copperwynd Financial sold out of Biogen (BIIB) in Q3 2023, closing a stake of 6,250 shares — an estimated $1.78M sold.

Copperwynd Financial first reported a position in BIIB in Q4 2017 and held it in 5 quarters. The position peaked at $1.78M in Q2 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Copperwynd Financial reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Copperwynd Financial sold 6,250 Biogen shares in Q3 2023, an estimated $1.78M.
  • Copperwynd Financial first reported a position in Biogen in Q4 2017 and held it in 5 quarters.
  • Copperwynd Financial's Biogen position peaked at $1.78M in Q2 2023.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Copperwynd Financial's 13F filing for Q3 2023, filed 7 Nov 2023.